Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country

被引：0
作者：
Banan M. Aiesh
Yazan Maali
Farah Qandeel
Siwar Omarya
Shatha Abu Taha
Suha Sholi
Ali Sabateen
Adham Abu Taha
Sa’ed H. Zyoud
机构：
[1] An-Najah National University Hospital,Department of Infection Prevention and Control
[2] An-Najah National University,Department of Medicine, College of Medicine and Health Sciences
[3] An-Najah National University Hospital,Department of General Surgery
[4] An-Najah National University,Department of Biomedical Sciences, Faculty of Medicine and Health Sciences
[5] An-Najah National University Hospital,Department of Pathology
[6] An-Najah National University,Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences
[7] An-Najah National University,Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences
[8] An-Najah National University Hospital,Clinical Research Center
来源：
BMC Infectious Diseases | / 23卷
关键词：
Carbapenem resistant Enterobacterales; Resistance; Meropenem;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 205 条
[1]  
Chia PY(2020)The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms Antimicrob Resist Infect Control 9 29-14
[2]  
Sengupta S(2013)Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010 Infect Control Hosp Epidemiol 34 1-84
[3]  
Kukreja A(2019)Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: a systematic review and reanalysis of quasi-experimental studies Clin Infect Dis 68 873-5
[4]  
S SLP(2020)Carbapenem-resistant bacilli in a hospital in southern Brazil: prevalence and therapeutic implications Braz J Infect Dis 24 380-68
[5]  
Ng OT(2021)Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions Eur J Clin Microbiol Infect Dis 40 2053-8
[6]  
Marimuthu K(2019)Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital Infect Drug Resist 12 461-24
[7]  
Sievert DM(2022)The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients PLoS ONE 17 e0262554-90
[8]  
Ricks P(2020)Carbapenemase Producers among extensive drug-resistant gram-negative pathogens recovered from Febrile Neutrophilic Patients in Egypt Infect Drug Resist 13 3113-9
[9]  
Edwards JR(2020)Carbapenem-resistant Enterobacteriaceae: a serious concern in cancer patients Access Microbiol 2 3-14
[10]  
Schneider A(2020)Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital Antimicrob Resist Infect Control 9 155-75
12345678910